- Home
- NX vs NEO Comparison
NX vs NEO Comparison
Compare NX & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NX
- NEO
- Stock Information
- Founded
- NX 1927
- NEO 2001
- Country
- NX United States
- NEO United States
- Employees
- NX N/A
- NEO N/A
- Industry
- NX Metal Fabrications
- NEO Precision Instruments
- Sector
- NX Industrials
- NEO Health Care
- Exchange
- NX Nasdaq
- NEO Nasdaq
- Market Cap
- NX 852.8M
- NEO 963.9M
- IPO Year
- NX N/A
- NEO 1999
- Fundamental
- Price
- NX $19.57
- NEO $5.16
- Analyst Decision
- NX Strong Buy
- NEO Buy
- Analyst Count
- NX 1
- NEO 8
- Target Price
- NX $38.00
- NEO $12.14
- AVG Volume (30 Days)
- NX 382.2K
- NEO 2.7M
- Earning Date
- NX 09-04-2025
- NEO 07-29-2025
- Dividend Yield
- NX 1.64%
- NEO N/A
- EPS Growth
- NX N/A
- NEO N/A
- EPS
- NX 0.39
- NEO N/A
- Revenue
- NX $1,625,028,000.00
- NEO $689,189,000.00
- Revenue This Year
- NX $49.00
- NEO $13.83
- Revenue Next Year
- NX $2.99
- NEO $11.35
- P/E Ratio
- NX $49.81
- NEO N/A
- Revenue Growth
- NX 47.66
- NEO 9.70
- 52 Week Low
- NX $15.30
- NEO $4.73
- 52 Week High
- NX $33.48
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- NX 51.69
- NEO 29.52
- Support Level
- NX $19.30
- NEO $4.81
- Resistance Level
- NX $20.20
- NEO $6.61
- Average True Range (ATR)
- NX 0.62
- NEO 0.40
- MACD
- NX -0.02
- NEO -0.17
- Stochastic Oscillator
- NX 70.05
- NEO 17.46
About NX Quanex Building Products Corporation
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.